BMB-202 is a selective serotonin 5-HT2A receptor agonist and psychedelic drug of the N-benzylphenethylamine family which is under development for the treatment of depressive disorders and post-traumatic stress disorder (PTSD).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.